R

REXGENERO LIMITED

49 employees

Ixaka is a private cell and gene therapy company with a focus on the natural power of the body to cure disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Autologous Cell Therapy and Regenerative Medicine
Therapeutics
Medical

Date founded

2015

Funding rounds raised

Total raised

$2M

from 2 investors over 2 rounds

R

REXGENERO LIMITED raised $324K on August 21, 2019

Investors: Innovate UK

R

REXGENERO LIMITED raised $2M on January 23, 2018

Investors: Innovate UK

FAQ